{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:27:27Z","timestamp":1771529247385,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.diagmicrobio.2008.05.010","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T21:40:49Z","timestamp":1216071649000},"page":"110-112","source":"Crossref","is-referenced-by-count":24,"title":["Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains"],"prefix":"10.1016","volume":"62","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Biedenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Wikler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib1","first-page":"1041","article-title":"Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001","volume":"51","author":"CDC","year":"2002","journal-title":"Morb. Mort. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib2","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014seventh edition, M7-A7","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib3","series-title":"Performance standards for antimicrobial susceptibility testing, 18th informational supplement, M100-S18","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/AAC.40.4.1020","article-title":"Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles","volume":"40","author":"Deguchi","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1248\/bpb.26.832","article-title":"Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs","volume":"26","author":"Han","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib7","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/JCM.27.12.2758-2766.1989","article-title":"Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline","volume":"27","author":"Jones","year":"1989","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2008.05.010_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/45.suppl_3.67","article-title":"Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods","volume":"45","author":"Jones","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1081\/DCT-200039708","article-title":"Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent","volume":"27","author":"Kim","year":"2004","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/jac\/dkl144","article-title":"Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae","volume":"57","author":"Kim","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib10","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AAC.00153-06","article-title":"Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents","volume":"50","author":"Kosowska-Shick","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jac\/dkl304","article-title":"In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent","volume":"58","author":"Kwon","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2008.05.010_bib12","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1086\/511422","article-title":"Update on the management of gonorrhea in adults in the United States","volume":"44","author":"Newman","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib13","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/AAC.01407-05","article-title":"In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2008.05.010_bib14","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2004.02.005","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993\u20132002: continuous increasing of ciprofloxacin-resistant isolates","volume":"24","author":"Tanaka","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2008.05.010_bib15","first-page":"488","article-title":"World Health Organization. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002","volume":"27","author":"WHO","year":"2003","journal-title":"Commun. Dis. Intell."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308002678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308002678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:51:37Z","timestamp":1588812697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889308002678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0732889308002678"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.05.010","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}